{"product_id":"liver-transplantation-isbn-9781119633983","title":"Liver Transplantation","description":"\u003cp\u003e\u003cb\u003eExplore this practical and step-by-step guide to managing liver transplant patients from leading international clinicians in Hepatology \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe newly revised Second Edition of \u003ci\u003eLiver Transplantation: Clinical Assessment and Management\u003c\/i\u003e delivers expert clinical guidance on best practices in managing the care of liver transplant patients. Authors are all experts in their field and cover a world-wide perspective. Organized in an accessible, stepwise fashion and packed with text features such as key points, the book covers all critical areas of each stage of the liver transplant journey, from assessment, to management on the list, to long term care. \u003c\/p\u003e \u003cp\u003eReaders will learn when to refer a patient for liver transplantation, how to assess a potential liver transplant recipient, learn the principles of the procedure and the long term management of the transplant recipient. \u003ci\u003eLiver Transplantation\u003c\/i\u003e provides the entire hepatology and surgical team the information required for a sound understanding of the entire procedure, from pre- to post-operative care and management. \u003c\/p\u003e \u003cp\u003eClinically oriented and management-focused, the book is far more accessible than the liver transplant sections in traditional hepatology textbooks. Readers will also enjoy: \u003c\/p\u003e \u003cul\u003e \u003cli\u003eA thorough discussion of when to refer a patient for liver transplantation, including general considerations and the use and abuse of prognostic models \u003c\/li\u003e \u003cli\u003eAn exploration of the selection, assessment, and management of patients on the transplant list, including how to manage a patient with chronic liver disease while on the waiting list \u003c\/li\u003e \u003cli\u003eA treatment of liver transplantation for acute liver failure (ALF), including assessment and management of ALF patients on the transplant waiting list \u003c\/li\u003e \u003cli\u003eA discussion of care of the liver transplant recipient after the procedure in the short and long term  \u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003ePerfect for gastroenterologists, hepatologists, and surgeons and other health care professionals managing patients with liver disease who are awaiting, undergoing and following liver transplantation, \u003ci\u003eLiver Transplantation: Clinical Assessment and Management \u003c\/i\u003ewill also earn a place in the libraries of medical students, residents, internal medicine physicians, and GI\/Hepatology trainees and all health care professionals providing clinical care to people with liver disease, before, during and after transplantation. \u003c\/p\u003e \u003cp\u003eList of Contributors x\u003c\/p\u003e \u003cp\u003eForeword to the Second Edition xx\u003c\/p\u003e \u003cp\u003eForeword to the First Edition xxi\u003c\/p\u003e \u003cp\u003ePreface xxii\u003c\/p\u003e \u003cp\u003eAbbreviations xxiii\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1 When to Refer a Patient for Liver Transplantation \u003c\/b\u003e\u003cb\u003e1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Overview on Organ Donation and Liver Transplantation 3\u003cbr\u003e\u003ci\u003eMichael Ronan Lucey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Predicting Outcomes and Use and Abuse of Prognostic Models 11\u003cbr\u003e\u003ci\u003eMoira B. Hilscher and Patrick S. Kamath\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 Selection, Assessment, and Management on the List \u003c\/b\u003e\u003cb\u003e19\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e3 Assessment of the Potential Transplant Recipient 21\u003cbr\u003e\u003ci\u003eMichael L. Volk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Frailty and the Potential Liver Transplant Candidate 27\u003cbr\u003e\u003ci\u003eMatthew J. Armstrong and Jennifer C. Lai\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Alcohol Use (excluding Alcohol-Related Liver Disease), Tobacco, Marijuana, and Illicit Drugs 33\u003cbr\u003e\u003ci\u003eJohn P. Rice\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 The Role of the Psychiatric Consultant in the Selection, Assessment, and Management of Liver Transplant Patients 39\u003cbr\u003e\u003ci\u003eRobert M. Weinrieb and Arpita Goswami-Banerjee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 When Liver Transplant Patients Do Not Adhere to Therapeutic Plans 48\u003cbr\u003e\u003ci\u003eKerry Webb and Rowena Jones\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Liver Transplant Assessment for Young People: Addressing the Needs of Young People with Liver Disease 55\u003cbr\u003e\u003ci\u003eMarianne Samyn and Jemma Marie Day\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Assessment and Management of the Patient with Hepatitis C 64\u003cbr\u003e\u003ci\u003eEmma L. Hathorn and David J. Mutimer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Management of Hepatitis B Virus Infection Pre Transplantation 68\u003cbr\u003e\u003ci\u003eBruno Roche and Didier Samuel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Transplantation for the Management of Malignancy 74\u003cbr\u003e\u003ci\u003eAdiba I. Azad, Julie K. Heimbach, and Gregory J. Gores\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Assessment and Management of the Liver Transplant Candidate with Acute-on-Chronic Liver Failure 82\u003cbr\u003e\u003ci\u003eGiovanni Perricone and Rajiv Jalan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Assessment and Management of the Transplant Candidate with Alcohol-Associated Liver Disease 96\u003cbr\u003e\u003ci\u003eStéphanie Faure, Magdalena Meszaros, Lucy Meunier, Hélène Donnadieu-Rigole, and Georges-Philippe Pageaux\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Non-alcoholic Fatty Liver Disease as an Indication for Liver Transplantation 104\u003cbr\u003e\u003ci\u003ePaul Horn and Philip N. Newsome\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Consent 109\u003cbr\u003e\u003ci\u003eChristopher J.E. Watson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Prehabilitation and General Management 116\u003cbr\u003e\u003ci\u003eMatthew J. Armstrong and Felicity R. Williams\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Removal of Patients from the Liver Transplant Waiting List 123\u003cbr\u003e\u003ci\u003eJohn O’Grady\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Palliative Care and Liver Transplantation 126\u003cbr\u003e\u003ci\u003eMina Rakoski and Puneeta Tandon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 Transplantation for Acute Liver Failure \u003c\/b\u003e\u003cb\u003e135\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e19 Assessment of the Patient with Acute Liver Failure 137\u003cbr\u003e\u003ci\u003eAshley Barnabas and John O’Grady\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Management of the Patient with Fulminant Hepatic Failure Awaiting Liver Transplantation 143\u003cbr\u003e\u003ci\u003eRobert J. Fontana\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4 Donation and Allocation \u003c\/b\u003e\u003cb\u003e153\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e21 Ethical and Legal Aspects of Organ Donation 155\u003cbr\u003e\u003ci\u003eJessica Mellinger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Liver Allocation, Including Principles of Organ Allocation 161\u003cbr\u003e\u003ci\u003eParita Patel and Michael Charlton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Living Donor Liver Transplant in Children 168\u003cbr\u003e\u003ci\u003eAdebowale A. Adeyemi, Elizabeth B. Rand, and Kim M. Olthoff\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Living Liver Donation in Adults 180\u003cbr\u003e\u003ci\u003eMohamed Rela and Ashwin Rammohan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Deceased Liver Donors: Standard and Expanded Criteria 190\u003cbr\u003e\u003ci\u003eShareef Syed and Sandy Feng\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Donor-Transmitted Disease 203\u003cbr\u003e\u003ci\u003eJames Neuberger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Liver Donation and Preservation 209\u003cbr\u003e\u003ci\u003eNavneet Tiwari and Hynek Mergental\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 Liver Retrieval and Preservation 223\u003cbr\u003e\u003ci\u003eCarlo D.L. Ceresa, Brian R. Davidson, Peter J. Friend, and Rutger J. Ploeg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 Alternatives to Whole Graft Liver Transplantation 236\u003cbr\u003e\u003ci\u003ePaolo Muiesan, Alessandro Parente, and Hector Vilca-Melendez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Surgical Aspects of Deceased Donor Transplantation 252\u003cbr\u003e\u003ci\u003eAmit Nair, K.V. Narayanan Menon, Cristiano Quintini, and Charles Miller\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 5 Care of the Liver Transplant Recipient \u003c\/b\u003e\u003cb\u003e265\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e31 Outcomes after Liver Transplantation 267\u003cbr\u003e\u003ci\u003eJames Neuberger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 Outpatient Follow-Up of Liver Transplant Recipients 276\u003cbr\u003e\u003ci\u003eAmardeep Khanna and James Ferguson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Medication Adherence 285\u003cbr\u003e\u003ci\u003eMaureen Whitsett and Josh Levitsky\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Transitional Care 299\u003cbr\u003e\u003ci\u003eFiona Thompson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Managing the Liver Transplant Recipient with Abnormal Liver Blood Tests 303\u003cbr\u003e\u003ci\u003eJoanna A. Leithead\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 The Immune System in Liver Transplantation: Rejection versus Tolerance 317\u003cbr\u003e\u003ci\u003ePalak J. Trivedi and Nick D. Jones\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 Immunosuppressive Medications: Liver Transplantation 334\u003cbr\u003e\u003ci\u003eTim Mitchell and Gerry MacQuillan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38 Immunosuppression in Liver Transplantation 344\u003cbr\u003e\u003ci\u003eNicholas Lim and John R. Lake\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e39 Patterns of Liver Allograft Rejection 353\u003cbr\u003e\u003ci\u003eGeoffrey W. McCaughan, Ken Liu, Avik Majumdar, Patrick Bertolino, David G. Bowen, and Simone I. Strasser\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40 De Novo Autoimmune Hepatitis 360\u003cbr\u003e\u003ci\u003eJames Neuberger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41 Managing Rejection 364\u003cbr\u003e\u003ci\u003eNeil Halliday and Douglas Thorburn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42 Withdrawal of Immunosuppression after Liver Transplantation 386\u003cbr\u003e\u003ci\u003eLuca Toti, Tommaso Maria Manzia, Francesca Blasi, and Giuseppe Tisone\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e43 Liver Transplant Pathology 393\u003cbr\u003e\u003ci\u003eOwen L. Cain and Stefan G. Hübscher\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e44 Care of the Liver Transplant Recipient: Management of Renal Function 403\u003cbr\u003e\u003ci\u003eAndres F. Carrion and Paul Martin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e45 Managing Cardiovascular Risk in the Liver Transplant Recipient 409\u003cbr\u003e\u003ci\u003eManhal Izzy and Kymberly D. Watt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e46 Bone Disease in Liver Transplantation 418\u003cbr\u003e\u003ci\u003eJohn Ayuk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e47 Diagnosis and Management of Recurrent Autoimmune Liver Disease 424\u003cbr\u003e\u003ci\u003eFernanda Q. Onofrio, Nazia Selzner, and Gideon M. Hirschfield\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e48 NAFLD and NASH in the Patient after Liver Transplantation 438\u003cbr\u003e\u003ci\u003ePaul Horn and Philip N. Newsome\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e49 Recurrent Metabolic Diseases 445\u003cbr\u003e\u003ci\u003eJames Neuberger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e50 Treatment of Hepatitis C in the Transplant Setting 449\u003cbr\u003e\u003ci\u003eJeffrey Kahn and Norah A. Terrault\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e51 Management of Hepatitis B Virus Infection Post Transplantation 458\u003cbr\u003e\u003ci\u003eBruno Roche and Didier Samuel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e52 Antimicrobial Prophylaxis Following Liver Transplantation 469\u003cbr\u003e\u003ci\u003eMichael J. Williams and Peter C. Hayes\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e53 Cytomegalovirus and the Liver Transplant Recipient 475\u003cbr\u003e\u003ci\u003eJames Ferguson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e54 Post-Liver Transplant Infections 481\u003cbr\u003e\u003ci\u003eMiruna David and Ahmed Elsharkawy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e55 De Novo Malignancies after Liver Transplantation 493\u003cbr\u003e\u003ci\u003eSimone I. Strasser, Ken Liu, Avik Majumdar, and Geoffrey W. McCaughan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e56 Post-Transplant Lymphoproliferative Disorders 500\u003cbr\u003e\u003ci\u003eJose Ignacio Herrero\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e57 Quality of Life and Employment after Liver Transplantation 507\u003cbr\u003e\u003ci\u003eSantiago Tome, Esteban Otero, and Michael Ronan Lucey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e58 Sexual Function, Fertility, and Pregnancy in Liver Disease and after Liver Transplantation 514\u003cbr\u003e\u003ci\u003ePatrizia Burra, Salvatore Stefano Sciarrone, and Patrizio Bo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e59 Common Drug Interactions 519\u003cbr\u003e\u003ci\u003eAmanda Smith\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e60 Immunization and Liver Transplantation 525\u003cbr\u003e\u003ci\u003eJessica Hause and Erin Spengler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePostscript 529\u003cbr\u003e\u003ci\u003eJames Neuberger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 531\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJAMES NEUBERGER, DM, FRCP\u003c\/b\u003e is Consultant Physician in the Liver Unit, Birmingham, UK. A previous President of the British Association for the Study of the Liver, he has over 35 years of liver transplantation and disease experience and has edited five books on liver disease and liver transplantation and published extensively in liver disease and transplantation.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJAMES FERGUSON, MD, FRCPE\u003c\/b\u003e is Consultant Hepatologist at the Queen Elizabeth Hospital in Birmingham, UK. He has extensive experience in managing patients with liver disease and in liver transplantation. \u003c\/p\u003e\u003cp\u003e\u003cb\u003ePHILIP N. NEWSOME, PHD, FRCPE\u003c\/b\u003e is Professor of Experimental Hepatology and Honorary Consultant Hepatologist, Director of Research and Knowledge Transfer for the College of Medical \u0026amp; Dental Sciences and Director of the Centre for Liver and Gastrointestinal Research in the University of Birmingham, UK. Currently Secretary General of the European Association for the Study of the Liver, he continues to research in all aspects of liver disease and stem cell therapy. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eMICHAEL RONAN LUCEY, MD, FRCPI\u003c\/b\u003e is Chief of the Division of Gastroenterology and Hepatology at the University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. A past President of the American Society of Transplantation, he continues to publish widely in the field of liver disease and liver transplantation.  \u003c\/p\u003e\u003cp\u003e\u003cb\u003eA COMPLETE GUIDE TO THE MANAGEMENT OF PATIENTS AT EVERY STAGE OF LIVER TRANSPLANTATION\u003c\/b\u003e  \u003c\/p\u003e\u003cp\u003eThe newly revised Second Edition of \u003ci\u003eLiver Transplantation: Clinical Assessment and Management\u003c\/i\u003e delivers expert clinical guidance on best practices in managing the care of liver transplant patients. Each author is a leader in their field and together they cover a world-wide perspective, addressing all critical areas of each stage of the liver transplant journey, from assessment, to management on the list, to long-term care. \u003c\/p\u003e\u003cp\u003eReaders will learn when to refer a patient for liver transplantation, how to assess a potential liver transplant recipient, procedural principles and the long-term management of the transplant recipient. \u003ci\u003eLiver Transplantation\u003c\/i\u003e provides the entire hepatology and surgical team with the information required for a sound understanding of the entire procedure, from pre- to post-operative care and management. \u003c\/p\u003e\u003cp\u003eClinically oriented and management-focused, the book is far more accessible than the liver transplant sections in traditional hepatology textbooks, offering: \u003c\/p\u003e\u003cli\u003e\u003cbl\u003eA thorough discussion of when to refer a patient for liver transplantation, including general considerations and the use and potential misuse of prognostic models\u003c\/bl\u003e\u003c\/li\u003e \u003cli\u003e\u003cbl\u003eAn exploration of the selection, assessment, and management of patients on the transplant list, including how to manage patients with chronic liver disease\u003c\/bl\u003e\u003c\/li\u003e \u003cli\u003e\u003cbl\u003eAn examination of liver transplantation for acute liver failure (ALF), including assessment and management of ALF patients on the transplant waiting list\u003c\/bl\u003e\u003c\/li\u003e \u003cli\u003e\u003cbl\u003eA discussion of care of the liver transplant recipient after the procedure in the short and long term\u003c\/bl\u003e\u003c\/li\u003e \u003cp\u003eDesigned for gastroenterologists, hepatologists, surgeons and other health care professionals managing patients with liver disease who are awaiting, undergoing or recovering from transplantation, \u003ci\u003eLiver Transplantation: Clinical Assessment and Management\u003c\/i\u003e is a practical and authoritative guide to all aspects of this complex and vital procedure.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989537439973,"sku":"NP9781119633983","price":172.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119633983.jpg?v=1761784508","url":"https:\/\/k12savings.com\/es\/products\/liver-transplantation-isbn-9781119633983","provider":"K12savings","version":"1.0","type":"link"}